Reference field note
Dulaglutide
A reference record with its source links, an editorial reading note, and questions to carry forward.
Aliases: Trulicity
- Status
- Approved product
- Evidence label
- Randomized evidence
- Index topics
- Metabolism
- Status as of
The record
Recorded fields
- Mechanism
- GLP-1 receptor agonist fusion protein.
- Evidence
- Randomized studies.
- Limitations
- No weight-management indication.
- Safety
- Not recommended for severe gastroparesis.
- Route context
- Subcutaneous injection.
- Approval scope
- Trulicity: specified type 2 diabetes populations.
Pause and consider
A reading note
An example can help explain an idea without reporting something that happened. Notice whether a passage invites you to imagine a situation or presents an account for examination. For an imagined situation, follow the relationship it is meant to illustrate and ask whether the example makes that relationship clear. Do not carry its invented details into your notes as observations. If a writer moves from illustration to a claim about the world, mark that transition. The illustration may clarify the claim, but the claim still needs support appropriate to what it asserts.
Questions to carry forward
- Is this example offered as an illustration or as an account of something observed?
- Which relationship is the imagined situation intended to make easier to understand?
- Where does the passage move from explaining an idea to asserting something about the world?
Follow the record
References
- TRULICITY
NLM · Checked
Prepared by the Panda Bear editorial team. Educational information; no independent medical review is claimed.